Clinical Trial Update: To Assess the Efficacy, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans Progressiva [Phase 2]

View source ↗

Summary

This clinical trial update indicates that INCB000928 is being studied in Phase 2 for fibrodysplasia ossificans progressiva and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibrodysplasia Ossificans Progressiva

Drugs mentioned

• INCB000928

Snippet

Sponsor: Incyte Corporation | Conditions: Fibrodysplasia Ossificans Progressiva (FOP) | Phase 2 | Status: RECRUITING